Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Different Molecular-Weight Hyaluronic Acid in Subdeltoid Bursitis
NCT07729514Phase 4Not yet recruiting
- Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital
- Start
- Aug 2026
- Primary completion
- Jun 2027
01
Overview
A Phase 4 trial of ultra-high molecular weight hyaluronic acid in subdeltoid bursitis, sponsored by Shin Kong Wu Ho-Su Memorial Hospital. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
ultra-high molecular weight hyaluronic acid
03
Conditions
subdeltoid bursitis
Beyond the preview
Go deeper on NCT07729514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07729514.